3.29

0.22% 0.0073

Pre-market: 3.28 -0.01 -0.30%

Nanobiotix Adr (NBTX)

Overview News Price History Discussions Forecast

Nanobiotix Adr stock is traded at $3.29, with a volume of 2,637. It is up +0.22% in the last 24 hours and down -1.79% over the past month. Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Previous Close:

$3.2827

Open:

$3.39

24h Volume:

2,637

Relative Volume:

0.23

Market Cap:

$157.86M

Revenue:

$27,600

Net Income/Loss:

$-36.04M

P/E Ratio:

-4.129

EPS:

-0.7968

Net Cash Flow:

$-1.66M

1W Performance:

+3.54%

1M Performance:

-1.79%

6M Performance:

-30.15%

1Y Performance:

-38.85%

1-Day Range:

$3.29

$3.5499

1-Week Range:

$3.21

$3.5499

52-Week Range:

$2.76

$7.51

Nanobiotix Adr Stock (NBTX) Company Profile

Name

Nanobiotix Adr

Sector

Healthcare (1151)

Industry

Biotechnology (660)

Phone

Address

Employee

108

Twitter

Next Earnings Date

2025-04-02

Latest SEC Filings

NBTX's Discussions on Twitter

Compare NBTX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NBTX Nanobiotix Adr	3.29	157.86M	27,600	-36.04M	-1.66M	-0.7968
VRTX Vertex Pharmaceuticals Inc	489.10	127.47B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	563.16	62.43B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	596.20	37.03B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	234.56	31.06B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	230.98	26.16B	3.81B	-644.79M	-669.77M	-6.24